These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14583236)

  • 1. Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat.
    MacNeil BJ; Jansen AH; Greenberg AH; Nance DM
    Brain Behav Immun; 2003 Dec; 17(6):442-52. PubMed ID: 14583236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acute adrenalectomy on sympathetic responses to peripheral lipopolysaccharide or central PGE(2).
    MacNeil BJ; Jansen AH; Greenberg AH; Nance DM
    Am J Physiol Regul Integr Comp Physiol; 2000 May; 278(5):R1321-8. PubMed ID: 10801303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential relationship between actions of CRF and PGE2 in the brain on splenic sympathetic nerve activity in rats.
    Katafuchi T; Ichijo T; Hori T
    J Auton Nerv Syst; 1997 Dec; 67(3):200-6. PubMed ID: 9479672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular injection of prostaglandin E2 increases splenic sympathetic nerve activity in rats.
    Ando T; Ichijo T; Katafuchi T; Hori T
    Am J Physiol; 1995 Sep; 269(3 Pt 2):R662-8. PubMed ID: 7573569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central effects of prostaglandin E2 on blood pressure and plasma renin activity in rats. Role of the sympathoadrenal system and vasopressin.
    Okuno T; Lindheimer MD; Oparil S
    Hypertension; 1982; 4(6):809-16. PubMed ID: 6292084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral endotoxin increases splenic sympathetic nerve activity via central prostaglandin synthesis.
    MacNeil BJ; Jansen AH; Janz LJ; Greenberg AH; Nance DM
    Am J Physiol; 1997 Aug; 273(2 Pt 2):R609-14. PubMed ID: 9277545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intragastric injection of Lactobacillus casei strain Shirota suppressed spleen sympathetic activation by central corticotrophin-releasing factor or peripheral 2-deoxy-d-glucose in anesthetized rats.
    Tanida M; Takada M; Kato-Kataoka A; Kawai M; Miyazaki K; Shibamoto T
    Neurosci Lett; 2016 Apr; 619():114-20. PubMed ID: 26971699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interleukin-1 beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in conscious rats.
    Shimizu N; Hori T; Nakane H
    Brain Behav Immun; 1994 Mar; 8(1):14-23. PubMed ID: 8003768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
    Ingram CD; Tolchard S
    J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of central oxytocin in the inhibition by endotoxin of distension-stimulated gastric acid secretion.
    Calatayud S; Quintana E; Esplugues J; Barrachina MD
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):676-82. PubMed ID: 10619185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type.
    Lacroix S; Valliéres L; Rivest S
    J Neuroimmunol; 1996 Nov; 70(2):163-79. PubMed ID: 8898725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin pretreatment enhances arginine vasopressin-induced motor disturbances and arginine vasopressin-induced phosphoinositol hydrolysis in rat septum: a cross-sensitization phenomenon.
    Poulin P; Pittman QJ
    J Neuroendocrinol; 1993 Feb; 5(1):33-9. PubMed ID: 8387375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of opioids and vasopressin in central action of angiotensin II in conscious rabbits.
    Fukuhara M; Matsumura K; Abe I; Fujishima M
    Hypertens Res; 1998 Jun; 21(2):89-95. PubMed ID: 9661804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorectic action of bombesin requires receptor for corticotropin-releasing factor but not for oxytocin.
    Plamondon H; Merali Z
    Eur J Pharmacol; 1997 Dec; 340(2-3):99-109. PubMed ID: 9537828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central interleukin-1 beta enhances splenic sympathetic nerve activity in rats.
    Ichijo T; Katafuchi T; Hori T
    Brain Res Bull; 1994; 34(6):547-53. PubMed ID: 7922597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas.
    Yibchok-Anun S; Cheng H; Heine PA; Hsu WH
    Am J Physiol; 1999 Jul; 277(1):E56-62. PubMed ID: 10409128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain oxytocin receptors mediate corticotropin-releasing hormone-induced anorexia.
    Olson BR; Drutarosky MD; Stricker EM; Verbalis JG
    Am J Physiol; 1991 Feb; 260(2 Pt 2):R448-52. PubMed ID: 1847605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide W stimulates adrenocorticotrophic hormone release via corticotrophin-releasing factor but not via arginine vasopressin.
    Yogo K; Oki Y; Iino K; Yamashita M; Shibata S; Hayashi C; Sasaki S; Suenaga T; Nakahara D; Nakamura H
    Endocr J; 2012; 59(7):547-54. PubMed ID: 22484995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neurohypophyseal antagonists in postnephrectomy natriuresis in male rats.
    Huang W; Lee SL; Sjöquist M
    Kidney Int; 1994 Mar; 45(3):692-9. PubMed ID: 8196272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.